Sinofn Health
Sinofn Health
Explore our top scientific formulations crafted for precision wellness, sports nutrition, and therapeutic support.
Analyzing market dynamics, supply chain integration, and the rise of science-led contract manufacturing.
The global dietary supplements market is undergoing a structural paradigm shift. No longer satisfied with generic "white-label" vitamins, modern consumers demand high bioavailability, clean label assurances, and clinically backed efficacy. Private label supplement brands are increasingly acting as specialized category innovators, requiring contract manufacturers (OEMs/ODMs) to step up as end-to-end R&D partners rather than simple toll processors.
As a national high-tech enterprise, SINOFN Health Co., Ltd. stands at the convergence of raw material innovation, advanced delivery formats, and metabolic health expertise. Strategically centered in Shanghai since 2025 as our global integration hub, we build on the deep scientific legacy of our parent company founded in 2012, delivering robust global supply chain compliance for market entry across North America, Europe, Asia-Pacific, and the Middle East.
SINOFN was forged out of clinical necessity. During her early clinical practices, Mrs. GuoHong Liu witnessed the devastating financial and physical struggles of families managing children with Phenylketonuria (PKU). Because specialized metabolic diets were prohibitively expensive and imported from overseas, she recognized a critical gap in native medical nutritional capabilities.
In 2012, Mrs. Liu established SINOFN with the clear objective of democratizing science-backed therapeutic diets. This vision successfully attracted strategic capital and scientific partnerships, transforming the company from a domestic PKU food developer into an industry leader in FSMP (Foods for Special Medical Purposes), clinical dietary formulas, and premium global nutraceuticals.
"We measure success not just in raw manufacturing throughput, but in our capacity to elevate global wellness through clinical validation and accessible biotechnology." — Mrs. GuoHong Liu
Backed by the Chinese Academy of Sciences (CAS), our formulation engineers develop elite-level delivery systems.
Through institutional alliances with major universities and continuous talent acquisition, SINOFN has structured a highly specialized research network. Led by prestigious researchers, we bridge the gap between biological discovery and consumer supplement commercialization.
Associate Researcher and Chinese Academy of Sciences Postdoctoral Fellow. A renowned expert in target-specific bioactive compound delivery systems and molecular stabilization.
Ph.D. from Peking University Medical School. Over 15 years designing specialized metabolic disorder diets, FSMP products, and clinical micro-nutrition profiles.
Senior Scientist from the Netherlands. Specializes in EU regulatory dynamics and novel bio-ingredient carrier systems like liposomes and enteric-coated formulations.
Take a tour of our smart-factory environments engineered to meet global quality standards.
10+ dedicated high-speed automated production lines covering softgels, gummies, tablets, capsules, and powder filling.
Equipped with high-performance liquid chromatography (HPLC) and GC-MS for precise active compound quantification and contaminant screening.
Dedicated facility for small-scale prototyping, sensory optimization, and real-time stability testing under variable humidity/temperature conditions.
Climate-controlled storage integrated with digital inventory systems to ensure absolute batch isolation and global safety compliance.
How SINOFN integrates pharmaceutical-grade extraction with wellness products for superior efficacy.
Many botanical compounds and fat-soluble vitamins (such as CoQ10, Curcumin, and Vitamin D3) suffer from low oral bioavailability. Our lab processes encapsulate these active molecules within phospholipid bilayers, shielding them from stomach acid degradation and accelerating cellular uptake.
Using biodegradable and plant-derived enteric coatings, we design tablets and capsules that bypass the stomach's acidic environment, releasing vital nutrients directly in the small intestine for optimized metabolic assimilation.
Traditional gummy manufacturing compromises heat-sensitive active ingredients. SINOFN utilizes low-temperature starch-free pectin deposition technologies, allowing high loading dosages of heat-sensitive probiotics, vitamins, and botanical extracts without loss of potency.
By utilizing white kidney bean, enoki mushroom extracts, and premium dietary fibers, we create prebiotic carrier systems that support beneficial gut microbiota. This scientific synergy optimizes digestion and metabolic pathways.
Simplifying market entry and regulatory approval across major global jurisdictions.
We design products according to Title 21 CFR Part 111 cGMP standards. All packaging templates undergo review to ensure compliant supplement facts panels, structure-function claims validation, and GRAS status confirmation for raw materials.
European markets demand strict compliance with EFSA health claim limits. Our formulation teams optimize ingredient selections, ensuring they align with clean label expectations, non-GMO requirements, and European botanical positive lists.
With certified Halal compliance, we provide formulation and manufacturing services that cater to the Middle East and Southeast Asian markets. We support regulatory registrations to facilitate international trade clearance.
Operating with certified quality systems and robust intellectual property protections.
SINOFN prioritizes intellectual property and rigorous quality systems. Our operations hold 36 patents (including 11 invention patents, 12 utility models, 11 software copyrights, and 2 design patents) and 71 multi-category trademarks.
Common questions from global distributors, brand managers, and sourcing partners.
Our core production facility is located in Tianjin, spanning an industrial footprint of 53,000 square meters. In 2025, we established our corporate export and trading hub in Shanghai to manage logistics, custom documentation, and communication with our global brand partners.
Yes. Our R&D center is equipped with pilot-scale systems specifically designed for new formulations, tablets, and liquids. This allows us to test and optimize taste profile, stability, and active compound release before moving to large-scale production.
We are certified under ISO 9001, ISO 22000, and HACCP quality management systems. Furthermore, our raw materials and processing facilities are HALAL certified, and we utilize BRCGS-compliant warehousing to meet import requirements in the US, Europe, and Asia-Pacific.
SINOFN works in close partnership with the Chinese Academy of Sciences (CAS). Our R&D Lead, Dr. Zhang Ying, is a CAS Postdoctoral Fellow and Associate Researcher, guiding our team in developing and testing advanced compound delivery systems.
Yes. Guided by Dr. Tan Shengjie (Peking University Medical Ph.D.) and Hans van Dijk, we specialize in functional medical foods, including low-protein metabolic formulas for Phenylketonuria (PKU) patients and target-release dietary supplements.
Explore our specialized metabolic foods, high-absorption capsules, and therapeutic dietary support options.
